Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Candida albicans is a pathogenic yeast of important public health relevance. Virulence of C. albicans requires a copper and zinc containing superoxide dismutase (SOD1), but the biology of C. albicans SOD1 is poorly understood. To this end, C. albicans SOD1 activation was examined in baker's yeast (Saccharomyces cerevisiae), a eukaryotic expression system that has proven fruitful for the study of SOD1 enzymes from invertebrates, plants, and mammals. In spite of the 80% similarity between S. cerevisiae and C. albicans SOD1 molecules, C. albicans SOD1 is not active in S. cerevisiae. The SOD1 appears incapable of productive interactions with the copper chaperone for SOD1 (CCS1) of S. cerevisiae. C. albicans SOD1 contains a proline at position 144 predicted to dictate dependence on CCS1. By mutation of this proline, C. albicans SOD1 gained activity in S. cerevisiae, and this activity was independent of CCS1. We identified a putative CCS1 gene in C. albicans and created heterozygous and homozygous gene deletions at this locus. Loss of CCS1 resulted in loss of SOD1 activity, consistent with its role as a copper chaperone. C. albicans CCS1 also restored activity to C. albicans SOD1 expressed in S. cerevisiae. C. albicans CCS1 is well adapted for activating its partner SOD1 from C. albicans, but not SOD1 from S. cerevisiae. In spite of the high degree of homology between the SOD1 and CCS1 molecules in these two fungal species, there exists a species-specific barrier in CCS-SOD interactions which may reflect the vastly different lifestyles of the pathogenic versus the noninfectious yeast.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956745PMC
http://dx.doi.org/10.1007/s00775-013-1045-xDOI Listing

Publication Analysis

Top Keywords

albicans sod1
32
sod1
15
albicans
14
copper chaperone
12
cerevisiae albicans
12
pathogenic yeast
8
candida albicans
8
ccs1
8
sod1 ccs1
8
albicans ccs1
8

Similar Publications

In vitro evaluation of tolerance ability of cross-kingdom biofilm towards oral dynamic fluctuations.

BMC Oral Health

July 2025

Fujian Key Laboratory of Oral Diseases & Fujian Provincial Engineering Research, School and Hospital of Stomatology, Center of Oral Biomaterial & Stomatological Key lab of Fujian College and University, Fujian Medical University, Fuzhou, China.

Objectives: The aim of this study was to investigate the resilience of Streptococcus mutans (S. mutans) and Candida albicans (C. albicans) cross-kingdom biofilms in response to environmental stresses.

View Article and Find Full Text PDF

Computational prediction of Homo sapiens-Candida albicans protein-protein interactions reveal key virulence factors using dual RNA-Seq data analysis.

Arch Microbiol

April 2025

Artificial Intelligence for Computational Biology (AICoB) Laboratory, Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, Himachal Pradesh, 176061, India.

A prevalent pathobiont, Candida albicans, accounts for approximately 70% of fungal infections worldwide owing to its virulence traits that culminate in devastating fatalities within healthcare facilities. Protein-protein interactions (PPIs) between Homo sapiens and C. albicans play a pivotal role in infection and disease progression.

View Article and Find Full Text PDF

Antifungal Activity of Mefloquine Against Candida albicans Growth and Virulence Factors: Insights Into Mode of Action.

Curr Microbiol

June 2024

Department of Stem Cell and Regenerative Medicine & Medical Biotechnology, Centre for Interdisciplinary Research, DY Patil Education Society (Deemed to Be University), Kasaba Bawada, Kolhapur, Maharashtra, 416006, India.

The antimalarial drug Mefloquine has demonstrated antifungal activity against growth and virulence factors of Candida albicans. The current study focused on the identification of Mefloquine's mode of action in C. albicans by performing cell susceptibility assay, biofilm assay, live and dead assay, propidium iodide uptake assay, ergosterol quantification assay, cell cycle study, and gene expression studies by RT-PCR.

View Article and Find Full Text PDF

Candida albicans is the primary etiological agent associated with candidiasis in humans. Unrestricted growth of C. albicans can progress to systemic infections in the worst situation.

View Article and Find Full Text PDF

Transcriptomic meta-analysis to identify potential antifungal targets in Candida albicans.

BMC Microbiol

February 2024

Laboratory of Molecular Cell Biology, Department of Biology, Katholieke Universiteit Leuven, Kasteelpark Arenberg 31, Leuven, B-3001, Belgium.

Background: Candida albicans is a fungal pathogen causing human infections. Here we investigated differential gene expression patterns and functional enrichment in C. albicans strains grown under different conditions.

View Article and Find Full Text PDF